A study to compare two doses of a drug used for pain control given in a pain control technique for patients undergoing breast cancer surgery
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Breast Cancer
- Registration Number
- CTRI/2017/09/009830
- Lead Sponsor
- Sangeeta Chakraborty
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
ASA I & II
Exclusion Criteria
1. Patients who refrained from giving an informed consent
2. Those with spinal or chest wall deformity and/or local infection at site of block.
3. Patients with coagulopathy
4. Patients with hypersensitivity to either ropivacaine or dexmedetomidine
5. Patient who had cognitive abnormalities due to underlying psychiatric comorbidities or patients who were not cooperative.
6. Heart block, moderate or severe stenotic/regurgitant heart lesions.
7. Patient with BMI <18.5 or >30, height <150 cm and > 195 cm .
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method